Vaccine Experts' Meeting Scrapped Over Court Order Drama
Published Date: 3/27/2026
Notice
Summary
The Advisory Committee on Immunization Practices (ACIP) meeting set for March 18-19, 2026, has been canceled for now due to a court order. This affects healthcare experts and the public waiting on vaccine advice, delaying any new immunization updates. No costs or new dates are announced yet, so stay tuned for when the meeting will happen next!
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
ACIP Meeting Stayed; Vaccine Guidance Delayed
If you were waiting for new vaccine recommendations, the Advisory Committee on Immunization Practices (ACIP) meeting scheduled for March 18-19, 2026 was stayed pursuant to a preliminary order on March 16, 2026. The meeting is delayed until further notice and no new date is announced yet, which delays any new immunization updates.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06231 — Agency Forms Undergoing Paperwork Reduction Act Review
The CDC is asking for your thoughts on a survey about blood collection and use. They want to make sure the questions are clear, useful, and not too much work for people to answer. You’ve got 30 days to share your ideas before they finalize the forms, helping save time and money for everyone involved.
2026-06232 — Proposed Data Collection Submitted for Public Comment and Recommendations
The CDC wants your thoughts on new forms to keep research data super safe when sharing secret info for important studies. This affects researchers who need access to private data and helps protect everyone’s privacy without adding extra hassle. You’ve got until June 1, 2026, to share your ideas—no cost changes, just smarter security!
2026-05421 — World Trade Center (WTC) Health Program; Petition 026-Anti-Glomerular Basement Membrane (Anti-GBM) Glomerulonephritis; Finding of Insufficient Evidence
The WTC Health Program reviewed a request to add Anti-GBM Glomerulonephritis, a kidney disease, to its list of covered health conditions but found not enough proof to do so. This means people affected by this disease won’t get new benefits or coverage changes right now. The decision was made official on March 19, 2026, with no immediate money or timing changes.
2026-05136 — Solicitation of Nominations for Appointment to the Advisory Committee on Breast Cancer in Young Women
The CDC is looking for smart and passionate people to join a special team focused on breast cancer in young women. If you’re an expert or survivor under 45, you can apply by April 20, 2026, to help shape prevention, treatment, and support efforts. This is a great chance to make a real difference without any pay but with a big impact on health policies.
2026-05195 — Agency Forms Undergoing Paperwork Reduction Act Review
The CDC is asking for your thoughts on their new forms about health and air travel. They want to make sure these forms are useful, clear, and not too much work for people to fill out. You’ve got 30 days to share your ideas before the government decides, so don’t miss out!
2026-05196 — Agency Forms Undergoing Paperwork Reduction Act Review
The CDC is asking for your thoughts on their Maritime Illness Database and Reporting System forms before they get official approval. This review helps make sure the forms are useful, clear, and not too much work for people to fill out. You’ve got 30 days to share your ideas, so don’t miss your chance to help shape how this info is collected!
Previous / Next Documents
Previous: 2026-05947 — Self-Regulatory Organizations; NYSE American LLC; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change To Adopt a New Methodology for Assessment and Collection of the Options Regulatory Fee (ORF)
Starting soon, NYSE American will change how it charges the Options Regulatory Fee (ORF). Only options trades done on their exchange and cleared for customers will be charged this fee, matching what other exchanges do. This update affects traders using NYSE American and kicks in immediately, aiming for a fairer and clearer fee system.
Next: 2026-05949 — Lead Exposure and Prevention Advisory Committee; Notice of Charter Renewal
The CDC just renewed the Lead Exposure and Prevention Advisory Committee’s charter for two more years, keeping their mission alive through March 2028. This means the committee will keep advising on how to protect people from lead poisoning, especially kids and communities at risk. No new costs or big changes, just a green light to keep fighting lead hazards with expert advice.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in